Cantor Fitzgerald Assumes Harpoon Therapeutics (HARP) at Overweight
Tweet Send to a Friend
Cantor Fitzgerald analyst Jennifer Kim assumes coverage on Harpoon Therapeutics (NASDAQ: HARP) with a Overweight rating and a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE